<<

. 5
( 5 .)



stract 561
22. Dalgleish AG, Beverley PC, Clapham PR, et al. The CD4 (T4) antigen is an essential component of
the receptor for the AIDS retrovirus. Nature 1984, 312: 763-7.
http://amedeo.com/lit.php?id=6096719
23. Klatzmann D, Champagne E, Chamaret S, et al. T-lymphocyte T4 molecule behaves as the receptor
for human retrovirus LAV. Nature 1984, 312: 767-8. http://amedeo.com/lit.php?id=6083454
24. Edwards TG, Hoffman TL, Baribaud F, et al. Relationships between CD4 independence, neutraliza-
tion sensitivity and exposure of a CD4-induced epitope in an HIV-1 envelope protein. J Virol 2001,
75:5230-9. http://amedeo.com/lit.php?id=11333905
25. Levy JA, Mackewicz CE, Barker E. Controlling HIV pathogenesis: the role of the noncytotoxic anti-
HIV response of CD8+ T cells. Immunol Today 1996,17: 217-24.
http://amedeo.com/lit.php?id=8991383
26. Cocchi F, DeVico AL, Garzino-Demo A, Arya S, Gallo RC, Lusso P. Identification of RANTES, MIP-
1a, and MIP-1? as the major HIV-suppressive factors produced by CD8+ T cells. Science 1995, 270:
1811-5. http://amedeo.com/lit.php?id=8525373
27. Deng H, Liu R, Ellmeier W, et al. Identification of a major co-receptor for primary isolates of HIV-1.
Nature 1996, 381: 661-6. http://amedeo.com/lit.php?id=8649511
28. Doranz BJ, Rucker J, Yi Y, et al. A dual-tropic primary HIV-1 isolate that uses fusin and the ?-chemo-
kine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell 1996, 85: 1149-58.
http://amedeo.com/lit.php?id=8674120
29. Dragic T, Litwin V, Allaway GP, et al. HIV-1 entry into CD4+ cells is mediated by the chemokine re-
ceptor CC-CKR-5. Nature 1996, 381: 667-73. http://amedeo.com/lit.php?id=8649512
30. Feng Y, Broder CC, Kennedy PE, Berger EA. HIV-1 entry cofactor: functional cDNA cloning of a
seven-transmembrane, G protein-coupled receptor. Science 1996, 272: 872-7.
http://amedeo.com/lit.php?id=8629022
31. Chan DC, Fass D, Berger JM, Kim PS. Core structure of gp41 from the HIV envelope glycoprotein.
Cell 1997, 89: 263-73. http://amedeo.com/lit.php?id=9108481
32. Kilby JM, Hopkins S, Venetta TM, et al. Potent suppression of HIV-1 replication in humans by T-20, a
peptide inhibitor of gp41-mediated virus entry. Nat Med 1998, 4: 1302-7.
http://amedeo.com/lit.php?id=9809555
33. Deng HK, Unutmaz D, Kewalramani VN, Littman DR. Expression cloning of new receptors used by
simian and human immunodeficiency viruses. Nature 1997, 388: 296-300.
http://amedeo.com/lit.php?id=9230441
34. Liao F, Alkhatib G, Peden KWC, Sharma G, Berger EA, Farber JM. STRL-33, a novel chemokine re-
ceptor-like protein, functions as a fusion cofactor for both macrophage-tropic and T cell line-tropic
HIV-1. J Exp Med 1997, 185: 2015-23. http://amedeo.com/lit.php?id=9166430
35. Liu R, Paxton WA, Choe S, et al. Homozygous defect in HIV-1 coreceptor accounts for resistance of
some multiply-exposed individuals to HIV-1 infection. Cell 1996, 86: 367-77.
http://amedeo.com/lit.php?id=8756719
36. Biti R, Ffrench RF, Young J, Bennetts B, Stewart G, Liang T. HIV-1 infection in an individual homozy-
gous for the CCR5 deletion allele. Nature Med 1997, 3: 252-3.
4-24 1-




37. Dean M, Carrington M, Winkler C, et al. Genetic restrictions of HIV-1 infection and progression to
AIDS by a deletion allele of the CKR5 structural gene. Science 1996, 273: 1856-62.
http://amedeo.com/lit.php?id=8791590
38. Anzala AO, Ball TB, Rostron T, O'Brien SJ, Plummer FA, Rowland-Jones SL. CCR2-64I allele and
genotype association with delayed AIDS progression in African women. Lancet 1998, 351: 1632-3.
39. Winkler C, Modi W, Smith MW, et al. Genetic restriction of AIDS pathogenesis by an SDF-1
chemokine gene variant. Science 1998, 279: 389-93. http://amedeo.com/lit.php?id=9430590
40. Murakami T, Nakajima T, Koyanagi Y, et al. A small molecule CXCR4 inhibitor that blocks T cell line-
tropic HIV-1 infection. J Exp Med 1997, 186: 1389-93. http://amedeo.com/lit.php?id=9334379
41. Schols D, Struyf S, Van Damme J, et al. Inhibition of T-tropic HIV strains by selective antagonization
of the chemokine receptor CXCR4. J Exp Med 1997, 186: 1383-8.
http://amedeo.com/lit.php?id=9334378
42. Chen JD, Bai X, Yang AG et al. Inactivation of HIV-1 chemokine co-receptor CXCR-4 by a novel in-
trakine strategy. Nat Med. 1997,; 3:1110-6. http://amedeo.com/lit.php?id=9334722
43. Zou YR, Kottmann AH, Kuroda M, Taniuchi I, Littman DR. Function of the chemokine receptor
CXCR4 in haematopoiesis and in cerebellar development. Nature 1998, 393: 595-9.
http://amedeo.com/lit.php?id=9634238
44. Stremlau M, Owens CM, Perron MJ et al. The cytoplasmic body component TRIM5alpha restricts
HIV-1 infection in Old World monkey s. Nature 2004; 427: 848-853
45. Zack JA, Arrigo SJ, Weitsman SR, Go AS, Haislip A, Chen ISY. HIV-1 entry into quiescent primary
lymphocytes: Molecular analysis reveals a labile, latent viral structure. Cell 1990, 61: 213-22.
http://amedeo.com/lit.php?id=2331748
46. Chun TW, Carruth L, Finzi D, et al. Quantification of latent tissue reservoirs and total body viral load
in HIV-1 infection. Nature 1997, 387:183-8. http://amedeo.com/lit.php?id=9144289
47. Ganesh L, Burstein E, Guha-Niyogi A et al. The gene product murr1 restricts HIV-1 replication in rest-
ing CD4+ lymphocytes. Nature 2003; 426: 853-857
48. Kohl NE, Emini EA, Schleif WA, et al. Active HIV protease is required for viral infectivity. Proc Natl
Acad Sci USA, 1988, 85: 4686-90. http://amedeo.com/lit.php?id=3290901
49. Geijtenbeek TB, Torensma R, van Vliet SJ, et al. Identification of DC-SIGN, a novel dendritic cell-
specific ICAM-3 receptor that supports primary immune responses. Cell 2000, 100: 575-85.
http://amedeo.com/lit.php?id=10721994
50. Embretson J, Zupancic M, Ribas JL, et al. Massive covert infection of helper T lymphocytes and
macrophages by HIV during the incubation period of AIDS. Nature 1993, 362: 359-62.
http://amedeo.com/lit.php?id=8096068
51. Pantaleo G, Graziosi C, Demarest JF, et al. HIV infection is active and progressive in lymphoid tissue
during the clinically latent stage of disease. Nature 1993, 362: 355-8.
http://amedeo.com/lit.php?id=8455722
52. O'Brien WA, Grovit-Ferbas K, Namazi A, et al. HIV-type 1 replication can be increased in peripheral
blood of seropositive patients after influenza vaccination. Blood 1995, 86: 1082-9.
http://amedeo.com/lit.php?id=7620162
53. Tenner-Racz K, Stellbrink HJ, van Lunzen J, et al. The unenlarged lymph nodes of HIV-1-infected,
asymptomatic patients with high CD4 T cell counts are sites for virus replication and CD4 T cell pro-
liferation. The impact of HAART. J Exp Med 1998, 187: 949-59.
http://amedeo.com/lit.php?id=9500797
54. Veazey RS, DeMaria MA, Chailfoux LV et al. Gastrointestinal tract as a myjor site of CD4 T cell de-
pletion and viral replication in SIV infection. Science 1998; 280: 427-31
55. Brenchley JM, Schacker TW, Ruff LE et al. CD4 T cell depletion during all stages of HIV disease oc-
curs predominantly in the gastrointestinal tract. J Exp Med 2004; 200: 749-59
56. Mehandru S, Poles MA, Tenner-Razc K et al. Primary HIV-1 infection is associated with preferential
depletion of CD4 T lymphocytes from effector sites in the gastrointestinal tract. J Exp Med 2004; 200:
761-70
57. Douek DC, Betts MR, Hill BJ et al. Evidence for increased T cell turnover and decreased thymic out-
put in HIV infection. J Immunol 2001; 167: 6663-8
58. Dion ML, Poulin JF, Bordi R et al. HIV infection rapidly induces and maintains a substantial suppres-
sion of thymocyte proliferation. Immunity 2004; 21: 757-68
59. Carrington M, Nelson GW, Martin MP, et al. HLA and HIV-1: heterozygote advantage and B*35-
Cw*04 disadvantage. Science 1999: 12, 28: 1748-52. http://amedeo.com/lit.php?id=10073943
4-25




60. Kaslow RA, Carrington M, Apple R, et al. Influence of combinations of human major histocompatibility
complex genes on the course of HIV-1 infection. Nat Med 1996: 2: 405-11.
http://amedeo.com/lit.php?id=8597949
61. Lockett SF, Robertson JR, Brettle RP, et al. Mismatched human leukocyte antigen alleles protect
against heterosexual HIV transmission. J Acq Imm Defic Syndr 2001: 27: 277-80.
http://amedeo.com/lit.php?id=11464148
62. Kaul R, Rowland-Jones SL, Kimani J, et al. New insights into HIV-1 specific cytotoxic T-lymphocyte
responses in exposed, persistently seronegative Kenyan sex workers. Immunol Lett 2001, 79: 3-13.
http://amedeo.com/lit.php?id=11595284
63. Rosenberg ES, Billingsley JM, Caliendo AM, et al. Vigorous HIV-1-specific CD4 T cell responses as-
socia-ted with control of viremia. Science 1997, 278: 1447-50.
http://amedeo.com/lit.php?id=9367954
64. Keet IP, Tang J, Klein MR, et al. Consistent associations of HLA class I and II and transporter gene
products with progression of HIV type 1 infection in homosexual men. J Infect Dis 1999, 180: 299-
309. http://amedeo.com/lit.php?id=10395843
65. Martin MP, Gao X, Lee JH, et al. Epistatic interaction between KIR3DS1 and HLA-B delays the pro-
gression to AIDS. Nat Genet. 2002, Aug;31(4):429-34. http://amedeo.com/lit.php?id=12134147
66. Goulder PJ, Phillips RE, Colbert RA, et al. Late escape from an immundominant cytotoxic T-
lymphocyte response associated with progression to AIDS. Nat Med 1997, 3: 212-7.
http://amedeo.com/lit.php?id=9018241
67. Pinto LA, Sullivan J, Berzofsky JA, et al. Env-specific cytotoxic T lymphocyte responses in HIV sero-
negative health care workers occupationally exposed to HIV contaminated body fluids. J Clin Invest
1995, 96: 867-76. http://amedeo.com/lit.php?id=7635981
68. Altfeld M, Allen TM, Yu XG, et al. HIV-1 superinfection despite broad CD8+ T-cell responses contain-
ing replication of the primary virus. Nature. 2002; 420: 434-9.
http://amedeo.com/lit.php?id=12459786
69. Harari A, Rizzardi GP, Ellefsen K et al. Analysis of HIV-1 and CMV specific memory CD4 T cell re-
sponses during primary and chronic infection. Blood 2002; 100: 1381-1387
70. Lichterfeld M, Yu XG, waring MT et al.HIV-1 specific cytotoxicity is preferentially mediated by a sub-
set of CD8+ T cells producing both interferon gamma and tumor necrosis factor alpha. J Exp Med
2004, 104, 487-494
71. Saha K, Zhang J, Gupta A et al. Isolation of primary HIV-1 that target CD8+ T lymphocytes using
CD8 as a receptor. Nat Med 2001, 7: 65-72. http://amedeo.com/lit.php?id=11135618
72. Douek DC, Brenchley JM, Betts MR et al. HIV preferentially infects HIV-specific CD4 T cells. Nature
2002; 417: 95-98
73. Lu W, Wu X, Lu Y, Guo W, Andrieu JM. Therapeutic dendritic-cell vaccine for simian AIDS. Nat Med
2003; 9(1): 13-14
74. Lu W, Arraes LC, Ferreira WT, Andrieu JM. Therapeutic dendritic-cell vaccine for chronic HIV-1 in-
fection. Nat Med 2004; 10 (12): 1359-1365
75. Walker CM, Moody DJ, Stites DP, Levy JA. CD8+ lymphocytes can control HIV infection in vitro by
suppressing viral replication. Science 1986, 234: 1563-6. http://amedeo.com/lit.php?id=2431484
76. Baier M, Werner A, Bannert N, Metzner K, Kurth R. HIV suppression by interleukin-16. Nature 1995,
378: 563.
77. Pal R, Garzino-Demo A, Markham PD, et al. Inhibition of HIV-1 infection by the a-chemokine MDC.
Science 1997, 278: 695-8. http://amedeo.com/lit.php?id=9381181
78. Zhang L, Yu W, He T et al. Contribution of human alpha-defensin 1, 2, and 3 to the anti-HIV-1 activity
of CD8 antiviral factor. Science 2002, 298: 995-1000.
79. Clerici M, Giorgi JV, Chou CC, et al. Cell-mediated immune response to HIV (HIV) type-1 in sero-
negative homosexual men with a recent sexual exposure to HIV-1. J Infect Dis 1992, 165: 1012-9.
http://amedeo.com/lit.php?id=1533867
80. Ferrantelli F, Rasmussen RA, Buckley KA et al. Complete protection of neonatal rhesus macaques
against oral exposure to pathogenic simian-human immunodeficiency virus by human anti-HIV mono-
clonal antibodies. J Infect Dis 2004; 189: 2167-2173
81. Schmitz JE, Kuroda MJ, Santra S et al. Effect of humoral immune responses on controlling viremia
during primary infection of rhesus monkeys with simian immunodeficiency virus. J Virol 2003; 77:
2165-2173
4-26 1-




82. Wong MT, Warren RQ, Anderson SA, et al. Longitudinal analysis of the humoral immune response to
HIV type 1 gp160 epitopes in rapidly progressing and nonprogressing HIV-1 infected subjects. J
Infect Dis 1993, 168: 1523-7. http://amedeo.com/lit.php?id=7504036
83. Hogervorst E, Jurriaans S, de Wolf F, et al. Predictors for non-and slow progression in HIV type 1 in-
fection: low viral RNA copy numbers in serum and maintenance of high HIV-1 p24-specific but not
V3-specific antibody levels. J Infect Dis 1995, 171: 811-21.
http://amedeo.com/lit.php?id=7706807
84. Montefiori DC, Pantaleo G, Fink LM, et al. Neutralizing and infection-enhancing antibody responses
to HIV type 1 in long-term nonprogressors. J Infect Dis 1996, 173: 60-7.
http://amedeo.com/lit.php?id=8537683
85. Mazzoli S, Trabattoni D, Lo Caputo S, et al. HIV-specific mucosal and cellular immunity in HIV-
seronegative partners of HIV-seropositive individuals. Nat Med 1997, 3:1250-7.
http://amedeo.com/lit.php?id=9359700

<<

. 5
( 5 .)